147 related articles for article (PubMed ID: 22736786)
21. Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection?
Joishy M; Jauhari P; Mathew AA; Rangarajan T
Arch Dis Child; 2008 Feb; 93(2):180-1. PubMed ID: 18208996
[No Abstract] [Full Text] [Related]
22. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.
Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
Int J Med Microbiol; 2018 Oct; 308(7):921-926. PubMed ID: 30257808
[TBL] [Abstract][Full Text] [Related]
23. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.
Safdar N; Said A; Gangnon RE; Maki DG
JAMA; 2002 Aug; 288(8):996-1001. PubMed ID: 12190370
[TBL] [Abstract][Full Text] [Related]
24. Clostridium septicum brain abscesses in a premature neonate.
Sadarangani SP; Batdorf R; Buchhalter LC; Mrelashvili A; Banerjee R; Henry NK; Huskins WC; Boyce TG
Pediatr Infect Dis J; 2014 May; 33(5):538-40. PubMed ID: 24220230
[TBL] [Abstract][Full Text] [Related]
25. [Haemolytic uraemic syndrome in children--a systematic review].
Bayat A; Kamperis K; Rittig S
Ugeskr Laeger; 2012 May; 174(19):1302-7. PubMed ID: 22564687
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.
Wong CS; Mooney JC; Brandt JR; Staples AO; Jelacic S; Boster DR; Watkins SL; Tarr PI
Clin Infect Dis; 2012 Jul; 55(1):33-41. PubMed ID: 22431799
[TBL] [Abstract][Full Text] [Related]
27. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.
Tajiri H; Nishi J; Ushijima K; Shimizu T; Ishige T; Shimizu M; Tanaka H; Brooks S
Int J Antimicrob Agents; 2015 Nov; 46(5):586-9. PubMed ID: 26391378
[TBL] [Abstract][Full Text] [Related]
28. A 2-year-old boy with hemolytic uremic syndrome and pneumocephalus.
Martin SE; Allen SD; Faught P; Hawley DA; Bonnin JM; Hattab EM
Brain Pathol; 2012 Jan; 22(1):121-4. PubMed ID: 22150928
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
Smith KE; Wilker PR; Reiter PL; Hedican EB; Bender JB; Hedberg CW
Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
[TBL] [Abstract][Full Text] [Related]
30. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome.
Buteau C; Proulx F; Chaibou M; Raymond D; Clermont MJ; Mariscalco MM; Lebel MH; Seidman E
Pediatr Infect Dis J; 2000 Jul; 19(7):642-7. PubMed ID: 10917223
[TBL] [Abstract][Full Text] [Related]
31. Hemolytic uremic syndrome risk and Escherichia coli O157:H7.
Tserenpuntsag B; Chang HG; Smith PF; Morse DL
Emerg Infect Dis; 2005 Dec; 11(12):1955-7. PubMed ID: 16485489
[TBL] [Abstract][Full Text] [Related]
32. Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.
Aldabe B; Delmas Y; Gault G; Vendrely B; Llanas B; Charron M; Castor C; Ong N; Weill F; Mariani-Kurkdjian P; Terrier F; Desjardin M; Simoes J; Le Bihan B; Combe C; Rolland P
Euro Surveill; 2011 Aug; 16(31):. PubMed ID: 21871216
[TBL] [Abstract][Full Text] [Related]
33. Prospective surveillance of Canadian children with the haemolytic uraemic syndrome.
Proulx F; Sockett P
Pediatr Nephrol; 2005 Jun; 20(6):786-90. PubMed ID: 15834619
[TBL] [Abstract][Full Text] [Related]
34. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
[TBL] [Abstract][Full Text] [Related]
35. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
Derad I; Obermann B; Katalinic A; Eisemann N; Knobloch JK; Sayk F; Wellhöner P; Lehnert H; Solbach W; Süfke S; Steinhoff J; Nitschke M
Nephrol Dial Transplant; 2016 Jan; 31(1):95-103. PubMed ID: 26180049
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
[TBL] [Abstract][Full Text] [Related]
37. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
Kakoullis L; Papachristodoulou E; Chra P; Panos G
J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
[TBL] [Abstract][Full Text] [Related]
38. Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness.
Ikeda K; Ida O; Kimoto K; Takatorige T; Nakanishi N; Tatara K
Epidemiol Infect; 2000 Jun; 124(3):343-9. PubMed ID: 10982057
[TBL] [Abstract][Full Text] [Related]
39. The management of VTEC O157 infection.
Todd WT; Dundas S
Int J Food Microbiol; 2001 May; 66(1-2):103-10. PubMed ID: 11407539
[TBL] [Abstract][Full Text] [Related]
40. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
